SecBot SecBot

SCLX

Scilex Holding Co
Nasdaq· Biological Products, (No Diagnostic Substances)· Inc. DE· CIK 0001820190 Biotech & Drug Discovery
$1.25 −0.18 (−12.59%)
Nov 16 4:00 PM ET · prev $1.43
Market cap
$13.2M
Nano cap
1 year
−87.1%
from $9.66 · Nov 17
30 days
−51.4%
from $2.57
52-week range
$1.25–14.02
at the low
Avg volume 20D
42.0K
shares / day
Short interest
132.2K
≈1.6% of shares · −10.9%
Days to cover
3.4
at average volume
Insider net
+$499.9K
2 buyers · 1 seller · 12 mo
New fund stakes
0
Q3 2026 13F · 0 exits
Filing reports
7
analyzed by SecBot
SecBot read MIXED 1 report · latest
Balance 0 bearish · 0 bullish · 1 mixed oldest → newest, height = score
Avg score

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBULLISH

    2 insiders bought $599.8K. 1 insider sold $100.0K.

  • InstitutionsMIXED

    Q3 2026: 4 added (0 new), 3 trimmed or exited.

  • Short sellersSTEADY

    Short interest −10.9% to 132.2K shares. 3.4 days to cover, ≈1.6% of shares.

  • TrendDOWNTREND

    62% below its 50-day average. New closing low $1.25 on Nov 16.

Who's buying

13F· Q3 2026
0
new positions
0
exits
FundMoveSharesValue
MORGAN STANLEYTRIM2,744$12.2K
US BANCORP \DE\DOUBLED2,004$8.9K
OSAIC HOLDINGS, INC.TRIM1,036$4.6K
Allworth Financial LPDOUBLED6$47.00
UBS Group AGDOUBLED33,376$260.3K
MORGAN STANLEYTRIM4,032$31.5K
OSAIC HOLDINGS, INC.DOUBLED2,339$18.2K
JONES FINANCIAL COMPANIES LLLPDOUBLED1,755$12.5K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

Last action Apr 2025
Recent actions
DateFirmActionRating
Apr 11, 2025D. Boral Capital
DOWNGRADE
DOWNGRADEHold
Apr 2, 2025D. Boral Capital
MAINTAIN
MAINTAINBuy
Feb 28, 2025D. Boral Capital
MAINTAIN
MAINTAINBuy
Jan 27, 2025D. Boral Capital
INITIATE
INITIATEBuy
Oct 21, 2024HC Wainwright & Co.
REITERATE
REITERATEBuy
Oct 16, 2024Alliance Global Partners
INITIATE
INITIATEBuy

Insider ledger

Form 4
$599.8K
bought · 2 insiders
$100.0K
sold · 1 insider
DateInsiderTypeValue
Jul 3, 2026
SCLX Stock Acquisition JV LLC
10%+ Owner
Jul 3, 2026
OTHER500,000 sh
Apr 17, 2026
Ma Stephen Hoi
CFO, COO and Secretary
Apr 17, 2026
BUY$100.0K
Apr 17, 2026
Ji Henry
Exec Chair, CEO and President
Apr 17, 2026
SELL$100.0K
Apr 16, 2026
Ji Henry
Exec Chair, CEO and President
Apr 16, 2026
BUY$499.9K

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current QNoneNoneNo data$0.00
Next QNoneNoneNo data$0.00
Current FYNoneNoneNo data$0.00
Next FYNoneNoneNo data$0.00

Short side

FINRA· Oct 30, 2026
132,205
shares short
-10.9%
vs prior settlement
3.4
days to cover
≈1.6%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Nov 13, 2026
Earnings date
🔒 Fresh data, subscribers only
Nov 12, 2026
Earnings date
SCLX Q3 2026 Earnings Scheduled · 2026-11-12
Aug 11, 2026
Earnings date
SCLX Q2 2026 Earnings Scheduled, 2026-08-11
Jul 6, 2026
Press release
Scilex Holding Company Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP
PALO ALTO, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative…
Jul 6, 2026
Clinical Trial
Safety and Efficacy of SP-103 in Subjects With Moderate to Severe Acute Lower Back Pain
Phase 2 · COMPLETED

SecBot reports

7 filings · 4 press releases · 0 bullish · 3 bearish · 3 mixed · 1 neutral
All SCLX filing & press-release reports (11)